先天性心脏病术后迁延性危重病的预测与生存
基于儿童心脏重症监护联盟注册登记的多中心观察性分析,纳入22家医院2419例新生儿和10687例非新生儿先心病术后患儿。迁延性危重病定义为住ICU时间第90百分位,新生儿≥35天、非新生儿≥10天。迁延性危重病组ICU病死率新生儿24%、非新生儿8%,显著高于非迁延组的5%和0.4%。多因素回归识别出新生儿10个、非新生儿19个迁延性危重病预测因素及8个死亡预测因素,仅机械通气天数和需肾脏替代治疗的急性肾衰竭在两个分层中均预测迁延性危重病及其死亡。约40%的迁延性危重病预测因素不可改变,而8个死亡预测因素中仅1个不可改变,其余为可预防的术后重症监护变量和并发症;各医院经病例组合调整后的迁延性危重病发生率存在差异,各有6家医院低于和高于预期。
要点
- 迁延性危重病 cutoff 为住ICU时间第90百分位:新生儿(≤28天)≥35天,非新生儿(29天至18岁)≥10天。
- 迁延性危重病组ICU病死率新生儿24%、非新生儿8%,而非迁延组分别为5%和0.4%。
- 仅机械通气天数和需肾脏替代治疗的急性肾衰竭在两个年龄分层中均预测迁延性危重病及其死亡。
- 约40%的迁延性危重病预测因素不可改变,但8个死亡预测因素中7个为可预防的术后重症监护变量和并发症。
- 22家医院经病例组合调整后,各有6家医院迁延性危重病频率低于和高于预期,提示存在可改善的实践差异。
适用人群与场景
- 纳入儿童心脏重症监护联盟(Pediatric Cardiac Critical Care Consortium)医院中先心病术后收入儿科心脏ICU的全部患者,按新生儿(≤28天)和非新生儿(29天至18岁)分层。
- 数据来源为儿童心脏重症监护联盟临床注册登记,共22家医院、2419例新生儿和10687例非新生儿。
诊断标准与关键阈值
- 迁延性危重病定义为住ICU时间第90百分位:新生儿≥35天,非新生儿≥10天。
研究设计与关键结果
- 多中心观察性分析,纳入22家医院2419例新生儿和10687例非新生儿先心病术后患儿,无干预。
- 迁延性危重病组ICU病死率新生儿24%、非新生儿8%,非迁延组分别为5%和0.4%。
- 多因素logistic回归识别新生儿10个、非新生儿19个迁延性危重病预测因素,以及8个死亡预测因素。
- 仅机械通气天数和需肾脏替代治疗的急性肾衰竭在两个分层中均预测迁延性危重病和迁延性危重病死亡。
- 约40%的迁延性危重病预测因素为不可改变因素(术前/患者因素和手术因素),8个死亡预测因素中仅1个为不可改变因素,其余为可预防的术后重症监护实施变量和并发症。
- 经病例组合调整后比较各医院迁延性危重病发生率,6家医院低于预期、6家医院高于预期。
证据类型、等级与局限
- 证据类型:观察性分析,基于儿童心脏重症监护联盟临床注册登记的多中心数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尽管许多迁延性危重病预测因素不可改变,但已识别出若干可针对改善的预测因素。
- 作者观察到并发症和迁延性重症监护治疗驱动迁延性危重病死亡。
- 作者认为,迁延性危重病频率的广泛差异提示,识别低于预期频率医院的实践可能推动更广泛的质量改进举措。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Prolonged critical illness after congenital heart surgery disproportionately harms patients and the healthcare system, yet much remains unknown. We aimed to define prolonged critical illness, delineate between nonmodifiable and potentially preventable predictors of prolonged critical illness and prolonged critical illness mortality, and understand the interhospital variation in prolonged critical illness.
DESIGN: Observational analysis.
SETTING: Pediatric Cardiac Critical Care Consortium clinical registry.
PATIENTS: All patients, stratified into neonates (≤28 d) and nonneonates (29 d to 18 yr), admitted to the pediatric cardiac ICU after congenital heart surgery at Pediatric Cardiac Critical Care Consortium hospitals.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: There were 2,419 neonates and 10,687 nonneonates from 22 hospitals. The prolonged critical illness cutoff (90th percentile length of stay) was greater than or equal to 35 and greater than or equal to 10 days for neonates and nonneonates, respectively. Cardiac ICU prolonged critical illness mortality was 24% in neonates and 8% in nonneonates (vs 5% and 0.4%, respectively, in nonprolonged critical illness patients). Multivariable logistic regression identified 10 neonatal and 19 nonneonatal prolonged critical illness predictors within strata and eight predictors of mortality. Only mechanical ventilation days and acute renal failure requiring renal replacement therapy predicted prolonged critical illness and prolonged critical illness mortality in both strata. Approximately 40% of the prolonged critical illness predictors were nonmodifiable (preoperative/patient and operative factors), whereas only one of eight prolonged critical illness mortality predictors was nonmodifiable. The remainders were potentially preventable (postoperative critical care delivery variables and complications). Case-mix-adjusted prolonged critical illness rates were compared across hospitals; six hospitals each had lower- and higher-than-expected prolonged critical illness frequency.
CONCLUSIONS: Although many prolonged critical illness predictors are nonmodifiable, we identified several predictors to target for improvement. Furthermore, we observed that complications and prolonged critical care therapy drive prolonged critical illness mortality. Wide variation of prolonged critical illness frequency suggests that identifying practices at hospitals with lower-than-expected prolonged critical illness could lead to broader quality improvement initiatives.
参考来源
- DeWitt AG, Rossano JW, Bailly DK, et al. Predicting and Surviving Prolonged Critical Illness After Congenital Heart Surgery. Crit Care Med. 2020. PMID: 32574468. doi:10.1097/CCM.0000000000004354
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。